Transformative Biotech Strengthens Its Presence at HudsonAlpha's Primer Lab for Innovative PCR Testing

Transformative Biotech Expands Operations at HudsonAlpha's Primer Lab

Transformative Biotech, LLC, a leading molecular diagnostics firm, has announced its residency at the Primer Lab located within the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. This new association underscores the company's ambition to drive advancements in direct-to-PCR testing, a crucial technology for infectious disease diagnostics.

Located in Boulder, Colorado, Transformative Biotech has established its research and development (R&D) operations at the Primer Lab, a vibrant startup incubator that offers over 4,000 square feet of collaborative lab space. This facility provides access to essential molecular and general lab equipment necessary for the company’s innovative projects, including its patented DirectAmp™ technology. According to the company’s CEO, Kevin Kraus, the partnership with HudsonAlpha allows them to operate in a capital-efficient manner, enabling them to generate significant data to support future lab and commercial partnerships.

What is DirectAmp™?

The DirectAmp™ technology is designed to simplify and expedite the PCR testing process by removing the need for nucleic acid extraction. This approach not only accelerates testing but also makes it more accessible and affordable. Transformative Biotech aims to promote rapid diagnostics in various settings, with the framework to perform tests at @ANYWHERE™. This innovation comes at a time when there is a pressing need for efficient and effective testing for infectious diseases, exemplifying the essential nature of their work.

The Benefits of Joining HudsonAlpha

By embedding itself within the ecosystem at HudsonAlpha, Transformative Biotech is positioned to leverage significant scientific expertise and collaborative opportunities. Dr. Mark Kelleher, the company’s Executive Vice President of R&D, emphasizes the importance of their new environment stating, "The Primer Lab gives us the infrastructure to accelerate our R&D..." This collaboration is expected to enhance the utility of DirectAmp™ across various sample types and testing applications, thereby broadening its impact and reach.

Notably, the Primer Lab was established with funding from Innovate Alabama to foster early-stage life sciences companies. This initiative not only provides physical space but also mentoring, support with grant applications, and connections to potential investors, greatly benefiting companies like Transformative Biotech.

Future Prospects

As Transformative Biotech continues its journey in the Primer Lab, it looks forward to integrating its operations with the HudsonAlpha community. The company expresses gratitude to the HudsonAlpha Economic Development team for this strategic opportunity, seeing immense potential in mutual collaboration that can lead to breakthroughs in molecular diagnostics.

In summary, Transformative Biotech’s residency at HudsonAlpha’s Primer Lab represents a strategic move to enhance its capabilities in R&D for direct-to-PCR technologies, promising advancements in infectious disease testing that are crucial for public health.

About Transformative Biotech

Transformative Biotech is dedicated to revolutionizing PCR testing for infectious diseases. Its pioneering technologies, including DirectAmp™, aim to simplify the diagnostic process, making it faster and more accessible.

About HudsonAlpha Institute for Biotechnology

HudsonAlpha is committed to harnessing the power of DNA to advance healthcare, agriculture, and education. As a nonprofit, it supports scientific innovation and economic growth in Alabama and beyond.